Sonnet BioTherapeutics has received a patent from the European Patent Office (EPO) for its fully human albumin binding (FHAB) technology.

European Patent Office (EPO) grants EU Patent No. EP3583125 B1 covering the Company’s Fully Human Albumin Binding (FHAB®) ...

InvisiShield Technologies Ltd., a biotechnology company revolutionizing respiratory viral protection with engineered intranasal antibodies that extend beyond the capabilities of vaccines, today ...

This study presents a valuable finding on the alterations in the autophagic-lysosomal pathway in a Huntington's disease model. The evidence supporting the claims of the authors is solid. However, the ...

PORTLAND, IA, UNITED STATES, January 28, 2025 /EINPresswire / -- According to the report, the global biosimilars <a target=_blank href= ...

Immunome, Inc. ("Immunome") , a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced its plans to commence an underwritten public ...

The global silicone additives market is expected to grow at 7% CAGR from 2024 to 2030. It is expected to reach above USD 2.70 billion by 2030 from USD 1.47 billion in 2023. Explore core findings and ...

Louise Digby, vice president of enzymes and bioproduction at BioProduction by SEKISUI, discusses some of the current ...

No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).

AstraZeneca and Daiichi Sankyo ’s antibody-drug conjugate (ADC) Enhertu (trastuzumab deruxtecan) has received approval from ...

Towana Looney has now lived longer than any person with a kidney from a pig. Looney's body produces antibodies that would reject most human kidneys. Before the pig transplant, she had to spend four ...

The Phase I ADC trial will evaluate the safety and efficacy of the company’s drug which targets tumours whilst leaving normal ...